Macular pigment and percentage of body fat

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 3940-3950

  Nolan, John ^a   O'Donovan, Orla ^a   Kavanagh, Heather ^a   Stack, Jim ^a   Harrison, Michael ^a   Muldoon, Annalouise ^a   Mellerio, John ^b   Beatty, Stephen ^a,c  

^a Ireland   (Ireland)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

^c WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ARTICLE; BODY FAT; BODY MASS; CORRELATION FUNCTION; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; NORMAL HUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; RETINA MACULA LUTEA; SEX DIFFERENCE;

ADIPOSE TISSUE; ADULT; BETA CAROTENE; BODY COMPOSITION; BODY MASS INDEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENSITOMETRY, X-RAY; DIET; FEMALE; FLICKER FUSION; FOOD HABITS; HUMANS; LUTEIN; MACULA LUTEA; MALE; MIDDLE AGED; PHOTOMETRY; RETINAL PIGMENTS; XANTHOPHYLLS;

EID: 6944243929     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0273     Document Type: Article

References (56)

1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
2. Reading VM, Weale RA. Macular pigment and chromatic aberration. J Opt Soc Am. 1974;64:231-234.
3. Beatty S, Koh HH, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
4. Hammond BR, Woolen BR, Snodderly DM. Density of the human crystalline lens is related to the macular pigment carotenoids, lutein and zeaxanthin. Optom Vis Sci. 1997;74:499-504.
5. Parker RS. Carotenoids in human blood and tissues. J Nutr. 1989; 119:101-104.
6. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem. 1990;8:1-10.
7. Hammond BR, Ciulla TA, Snodderly DM. Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci. 2002;43: 47-50.
8. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration associated with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121: 785-792.
9. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583-587.
10. Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106:910-919.
11. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8:237-249.
12. Klein B, Klein R, Lee K, Jensen S. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001;8:251-262.
13. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2004;107:2224-2232.
14. Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr. 1996;126:129-137.
15. Keys A, Taylor HL, Blackbur H, Brozek J, Anderson JT, Simonson E. Mortality and coronary heart disease among men studied for 23 years. Arch Intern Med. 1971;128:201-214.
16. Ringer TV, Deloof MJ, Winterrowd GE, et al. Beta-carotene's effects on serum lipoproteins and immunologic indices in humans. Am J Clin Nutr. 1991;53:688-694.
17. Rock C, Swendseid M. Plasma carotenoid levels in anorexia nervosa and obese patients. Methods Enzymol. 1993;214:116-123.
18. Bolton-Smith C, Casey C, Gey KF, Smith W, Tunstall-Pedoe H. Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers. Br J Nutr. 1991;65:337-346.
19. Bodner CH, Soutar A, New SA, et al. Validation of a food frequency questionnaire for use in a Scottish population: correlation of anti-oxidant vitamin intakes with biochemical measures. J Hum Nutr Diet. 1998;11:373-380.
20. New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: A cross-sectional study in pre-menopausal women. Am J Clin Nutr. 1997;65:1831-1839.
21. New SA, Bolton-Smith C. Development of a food frequency questionnaire. Proceedings of the Nutrition Society. Proc Nutr Soc. 1993;52:330.
22. Masson LF, McNeill G, Tomany JO, et al. Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr. 2003;6:313-321.
23. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson's The Composition of Foods. 5th ed. Cambridge, UK: Royal Society of Chemistry: 1991.
24. O'Neill ME, Carroll Y, Corridan B, et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr. 2001;85:499-507.
25. United States Department of Agriculture. USDA-NCC Carotenoid Database for U.S. Foods; Washington, DC: USDA; 1998. Available at http://www.nal.usda.gov/ fnic/foodcomp/Data/car98/car98.html.
26. Foods Standards Agency. McCance and Widdowson's The Composition of Foods. 6th ed. Cambridge, UK: Royal Society of Chemistry; 2002.
27. Rand WM, Windham CT, Wyse BW, Young VR. Food Composition Data: A User's Perspective. Toyko: United Nations University Press; 1987.
28. Rand WM, Windham CT, Wyse BW, Young VR. Compiling Data for Food Composition Databases. Tokyo: United Nations University Press; 1991.
29. Snodderly DM, Auran JD, Delori FC. The macular pigment. 2. Spatial-distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:674-685.
30. Mellerio J, Palmer DA, Rayner MJ. Macular pigment measurement with a novel portable instrument (Abstract). Ophthalmic Res. 1998;30:302.
31. Roubenoff R, Dallal GE, Wilson PWF. Predicting body fatness. The body-mass index vs. estimation by bioelectrical-impedance. Am J Pub Health. 1995;85:726-728.
32. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE. Reassessment of body-mass indexes. Am J Clin Nutr. 1990;52:405-408.
33. Segal KR, Dunaif A, Gutin B, Albu J, Nyman A, Pi-Sunyer FX. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. J Clin Invest. 1986; 80:1050-1055.
34. Berendschot TTJM, Willemse-Assink JJM, Bastiaanse M, De Jong PTVM, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci. 2002;43:1928-1932.
35. Broekmans WMR, Berendschot TTJM, Klopping-Ketelaars IAA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr. 2002;76:595-603.
36. Ciulla TA, Curran-Celantano J, Cooper DA, et al. Macular pigment optical density in a midwestern sample. Ophthalmology. 2001; 108:730-737.
37. Cooper DA, Curran-Celentano J, Ciulla TA, et al. Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis. J Nutr. 2000;130: 642-647.
38. Hammond BR, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci. 1992;33:350-355.
39. Thomson LR, Toyoda Y, Langner A, et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci. 2002;43:3538-3549.
40. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
41. Clevidence BA, Bieri JG. Association of carotenoids with human plasma-lipoproteins. Methods Enzymol. 1993;214:33-46.
42. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:786-796.
43. Viroonudomphol D, Pongpaew P, Tungtrongchitr R, et al. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr. 2003;12:73-79.
44. Bone RA, Landrum JT, Dixon Z, Chen Y, Lerena CM. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res. 2000;71:239-245.
45. Krinsky NI, Russen MD, Handelman GJ, Snodderly DM. Structural and geometrical isomers of carotenoids in human plasma. J Nutr. 1990;120:1654-1662.
46. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population based case control study. Arch Ophthalmol. 1995;113:1518-1523.
47. Gale CR, Hall NF, Phillips DIW, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44:2461-2465.
48. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration. Association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121:1728-1737.
49. Abalain JH, Carre JL, Leglise D, et al. Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? Clin Chim Acta. 2002;326:97-104.
50. Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42:439-446.
51. Hammond BR, Caruso-Avery M. Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci. 2000;41:1492-1497.
52. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis. 2001;18:1212-1230.
53. Gellermann W, Ermakov IV, Ermakov MR, McClane RW, Zhao DY, Bernstein PS. In vivo resonant Raman measurement of macular pigments in the young and the aging human retina. J Opthalmol Soc. 2002;19:1172-1186.
54. Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109:1780-1787.
55. Wooten BR, Hammond BR. Assessment of the Raman method of measuring human macular pigment (II) (E-Letter). Invest Ophthalmol Vis Sci. 2003.
56. Bernstein PS, Gellermann W. Author Response: Assessment of the Raman method of measuring human macular pigment (II) (E-Letter). Invest Ophthalmol Vis Sci. 2003.